Quick Search

 

 


 

 

Result Summary for 548-01

Result Summary
Protocol ID: 548-01
Clinical Study ID: 548-01
Official Title: GG548 (naratriptan) Phase I study (single oral dose study in healthy male volunteers).
Phase: Phase 1
Study Indications or Diseases:
  • Healthy Subjects
Generic Name: naratriptan
Trade/Product Name: amerge;naramig
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.